CAR-NK as a Rapidly Developed and Efficient Immunotherapeutic Strategy against Cancer

SIMPLE SUMMARY: New approaches in adoptive immunotherapy using chimeric antigen receptor (CAR)-modified cells have been developing very quickly in recent years, entering into clinical trials and being accepted by health agencies worldwide. Although the classical CAR therapies using genetically engin...

Descripción completa

Detalles Bibliográficos
Autores principales: Włodarczyk, Marta, Pyrzynska, Beata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817948/
https://www.ncbi.nlm.nih.gov/pubmed/36612114
http://dx.doi.org/10.3390/cancers15010117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817948/
https://www.ncbi.nlm.nih.gov/pubmed/36612114
http://dx.doi.org/10.3390/cancers15010117

Ejemplares similares